No abstract available
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay / Coelho T.; Dispenzieri A.; Grogan M.; Conceicao I.; Waddington-Cruz M.; Kristen A.V.; Wixner J.; Diemberger I.; Gonzalez-Moreno J.; Maurer M.S.; Plante-Bordeneuve V.; Garcia-Pavia P.; Tournev I.; Gonzalez-Costello J.; Cariou E.; Gonzalez-Duarte A.; Glass O.; Chapman D.; Amass L.. - In: AMYLOID. - ISSN 1350-6129. - STAMPA. - 30:4(2023), pp. 445-448. [10.1080/13506129.2023.2229484]
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay
Diemberger I.;
2023
Abstract
No abstract availableFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
903.61 kB
Formato
Adobe PDF
|
903.61 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
